Today: 20 May 2026
BellRing Brands stock slides 6% on securities-probe headline as BRBR nears 52-week low
5 January 2026
1 min read

BellRing Brands stock slides 6% on securities-probe headline as BRBR nears 52-week low

New York, January 5, 2026, 14:46 EST — Regular session

  • BRBR down about 6% in afternoon trade, after touching $23.96 intraday
  • Law firm Bleichmar Fonti & Auld said it opened a securities class action investigation
  • Focus shifts to early-February results for an update on demand and margins

Shares of BellRing Brands fell 6.1% to $24.49 in afternoon trading on Monday, after touching an intraday low of $23.96.

The move left the stock within about $2 of its 52-week low and roughly 70% below its 52-week high, extending a steep slide that has kept investors wary of the company’s near-term outlook.

That matters now because BellRing’s next quarterly update is approaching, and the stock is trading near levels that can force investors to reassess risk, especially after the company warned of a soft start to fiscal 2026.

Bleichmar Fonti & Auld LLP said in a Newsfile release that it is investigating BellRing Brands for potential violations of federal securities laws, a step that can precede a shareholder class action lawsuit.

BellRing’s drop outpaced the broader consumer-staples group: the Consumer Staples Select Sector SPDR fund was down about 0.2%, while packaged-food peer Simply Good Foods fell about 2.6% and Post Holdings slid about 2.3%.

BellRing, whose brands include Premier Protein and Dymatize, last set out its fiscal 2026 outlook in November, calling for net sales of $2.41 billion to $2.49 billion and adjusted EBITDA of $425 million to $455 million. Adjusted EBITDA is a profit measure that strips out interest, taxes and certain non-cash or one-time items to better show operating performance.

“We delivered strong results in 2025, with sales up 16%,” CEO Darcy Davenport said at the time, while noting the first quarter reflected “short-term challenges,” including an expected roughly 5% decline in net sales from a year earlier. Bellring

BellRing has also leaned on buybacks to support its stock. The company said its board approved a new $600 million share repurchase authorization over the next two years, replacing an earlier $400 million plan.

Still, the law-firm probe adds another overhang to a stock already sensitive to changes in demand signals and cost pressures, and any further reset in expectations could deepen the slide.

Stock Market Today

  • Euronext Q1 2026 Sees Record Trading Volumes and 15.3% Revenue Growth
    May 20, 2026, 5:43 AM EDT. Euronext reported a record Q1 2026 with cash equity trading and clearing revenue up 30.8% to €123 million, driven by high market volatility and the full contribution from Euronext Athens. Total underlying revenue rose 15.3% to €528.5 million, marking the exchange's eighth consecutive quarter of double-digit growth. Average daily cash equity transaction value in April reached €16.4 billion, with a 64.1% market share. Commodities trading revenue climbed 13.9%, while FX revenue grew 5.8%. ETF trading surged 84% since September 2025, boosted by the launch of mini ETF options. Adjusted EBITDA rose 16.7% to €343.2 million, with net income up 17.7%. Euronext declared a €3.18 dividend per share, reflecting a 50% payout, payable in May.

Latest articles

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

20 May 2026
New York, May 20, 2026, 05:08 EDT Co-Diagnostics shares face an early test on Wednesday after the diagnostic-test developer announced a $3 million private placement hours after its stock closed up 43.8% at $1.97 on Tuesday. Extended-hours trading showed the shares down 13.3% at $1.71 before the regular Nasdaq session. The timing matters. Co-Diagnostics had rallied after saying it had completed a strategy to develop an assay, or diagnostic test, for the Bundibugyo virus behind a fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda. The late financing then shifted attention to dilution and cash needs. The company said
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing
Previous Story

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next
Next Story

HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

Go toTop